Gravity Analytica

Compass Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference

CMPX 12.02.2024

SERA-AI Powered Highlights

Date of Upcoming Event:2024-12-04

Name of Upcoming Event:Piper Sandler 36th Annual Healthcare Conference

Full Press Release SEC Filings Our CMPX Tweets

About Gravity Analytica

Recent Filings

PDF Version

BOSTON, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will present at the Piper Sandler 36^thAnnual Healthcare Conference taking place in New York City, NY December 3-5, 2024.

Presentation detailsDate:Wednesday, December 4, 2024Time:9:50-10:10 AM ESTWebcast Link:https://event.webcasts.com/

Virtual/Replay availability:The corporate presentation will be archived for 90 days on Compass’Eventspage.

About Compass TherapeuticsCompass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. The company pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website athttps://www.compasstherapeutics.com.

Investor Contactir@compasstherapeutics.com

Media ContactAnna Gifford, Senior Manager of Communicationsmedia@compasstherapeutics.com617-500-8099

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com